Updated on: May 08, 2020 20:23 IST

DCGI approves clinical trials of Favipiravir used in influenza in Japan, China for COVID-19: CISR DG

The Certified Insurance Service Representative (CISR) Director General Dr. Shekhar C. Mande while talking about drugs that can be useful against COVID-19 informed that the Drug Controller General of India has given approval for clinical trials of Favipiravir which is used in influenza in Japan, China etc.